Directed molecular assembly into a biocompatible photosensitizing nanocomplex for locoregional photodynamic therapy. (2015)

Peer-Reviewed Study · Lee YD; Cho HJ; Choi MH; Park H; Bang J; Lee S; Kwon IC; Kim S · April 12, 2015

Lee YD et al., 2015-04-12: Human breast cancer xenograft study in which a methylene blue nanocomplex (NanoMB) injected around the tumour plus repeated laser irradiation suppressed tumour growth across five PDT sessions.

The quintuple PDT treatment by a combination of peritumorally injected NanoMB and selective laser irradiation suppressed the tumor volume efficaciously

Lee YD et al., 2015-04-12: Human breast cancer xenograft study in which a methylene blue nanocomplex (NanoMB) injected around the tumour plus repeated laser irradiation suppressed tumour growth across five PDT sessions. C5 Lee 2015. Study type: in vivo human breast cancer xenograft in mice, with in vitro work. N: not stated in the abstract. Country: South Korea (KIST). Dose: NanoMB (methylene blue self-assembled with fatty acid and a clinically approved polymer surfactant), peritumoural injection; laser wavelength/dose not stated in the abstract; five PDT treatments. Funder: 'Research Support, Non-U.S. Gov't'. Comparator: untreated and free-MB groups. NOTE: the agent is a formulated nanocomplex, not free methylene blue, and the paper claims suppression, not eradication or 'no regrowth'. Study type: animal.